The mean daily dose required to meet these goals was 20.8 mg in the atorvastatin group, 9.3 mg in the group started on 5 mg of rosuvastatin, and 13.4 mg in the group begun on 10 mg of rosuvastatin.

SATURN was designed to measure the impact of CRESTOR (rosuvastatin) 40 mg and atorvastatin 80 mg on the progression of atherosclerosis in high risk patients.

Patients on atorvastatin lost about 1 to 2 mL/min per 1.73 m2 over 52 weeks, those on rosuvastatin 10 mg/day lost about 4 mL/min per 1.73 m2, and those on rosuvastatin 40 mg/day lost close to 8 mL ...

For example, the Comparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin Simvastatin and Pravastatin Across Doses (STELLAR trial) showed that rosuvastatin 10 to 80 mg exhibited a ...

Like Crestor, Lipitor is processed in the liver and kidneys. Therefore, dose adjustments may need to be made in liver and kidney impairment. Liver enzymes also need to be monitored due to increased ...

Among those with CAD, both rosuvastatin and atorvastatin are similarly effective regarding the combination of all-cause death, MI, stroke, ... At 3 years, mean daily dose was higher in the ...

After a six-week dietary lead-in, 774 African-American adults with hypercholesterolemia were randomized to one of four open-label treatments for six weeks: CRESTOR 10 or 20 mg or atorvastatin 10 ...

However, the initial increase in blood glucose was more abrupt in the atorvastatin group (121.4 and 126.0 mg/dL at 3 and 6 months) compared to the rosuvastatin group (118.8 and 122.9 mg/dL at 3 ...

Data showed greater LDL-C reduction with CRESTOR 40mg compared with atorvastatin 80mg in patients at increased risk WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced results ...

In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. 7139956. Sign Up for Our Ideas Newsletter POV.

LONDON, January 15 /PRNewswire/ -- AstraZeneca (LSE: AZN) (NYSE: AZN) today announced the launch of a new clinical trial, SATURN, designed to measure the impact of CRESTOR(TM) (rosuvastatin) 40 mg ...